pretickt

VTRS peers and competitors

Viatris Inc. · end-of-day data as of Oct 16, 2026

Viatris Inc.
VTRS · $21.43B
$18.66+9.1%last 60 sessions · close Oct 16, 2026
$9.76$18.6652 weeks
Buy · 12 analystsPT $20.49 +9.8%
  • P/E vs own—
  • P/E vs sector—
  • Target upside+9.8%
  • Off 52w high0.0%
  • InsidersNone in 90d
  • FCF yield+8.7%
  • Earnings in20d
  • Trendbullish
  • Sector▲ +16.0%
  • RSI69
  • MA20×50—
  • Volume1.0x
  • Support-8.8%
  • Resistance—

VTRS’s peers by industry and size include Zoetis (ZTS), GE HealthCare Technologies (GEHC) and Alnylam Pharmaceuticals (ALNY). Among these 12 companies VTRS ranks 9th by market cap ($21.43B).

Peers by industry and size

20D
1ZTSZoetis Inc.$79.38+1.2%-45.2%+24.2%13.1$32.78B
2GEHCGE HealthCare Technologies Inc.$69.57-1.1%-21.0%+20.2%20.2$31.42B
3ALNYAlnylam Pharmaceuticals, Inc.$231.83-0.9%-52.8%+61.5%39.2$31.02B
4WSTWest Pharmaceutical Services, Inc.$384.02+0.3%0.0%+1.9%49.1$27.03B
5DGXQuest Diagnostics Incorporated$235.00-1.7%-4.7%-0.5%24.9$25.94B
6LHLabcorp Holdings Inc.$317.95-2.2%-6.1%+5.8%26.3$25.79B
7INCYIncyte Corporation$113.07-0.2%-13.0%+13.6%14.4$22.92B
8STESTERIS plc$222.66-0.7%-16.4%+24.2%27.2$21.71B
9VTRSViatris Inc.$18.66+2.4%0.0%+9.8%—$21.43B
10ZBHZimmer Biomet Holdings, Inc.$94.98+0.6%-7.7%+9.0%23.1$18.12B
11RVTYRevvity, Inc.$152.64-1.3%-3.0%-18.2%72.7$17.03B
12SOLVSolventum Corporation$85.81-2.3%-7.2%+3.6%10.5$14.61B

Data as of Oct 16, 2026 close.